Methods and compositions for determining risk of autism spectrum disorders
AssigneeThe Regents of the University of California
InventorJanine M. LaSalle
Life of this patent
Estimating the term…
Abstract
Described are methods for identifying an ASD risk gene, NHIP, and methods for determining the risk of an offspring for developing an ASD. A common structural variant disrupting the proximity of NHIP to a fetal brain enhancer was associated with NHIP expression and methylation levels and ASD risk, demonstrating a common genetic influence. NHIP is a novel environmentally-responsive ASD risk gene relevant to brain development in a previously under characterized region of the human genome.
Claims38
A method for determining a risk of an offspring for developing an autism spectrum disorder (ASD), the method comprising:
- detecting in a biological sample obtained from the offspring, mother or potential mother of the offspring expression and/or DNA methylation of a neuronal hypoxia inducible, placental associated (NHIP) gene, wherein decreased expression and/or decreased methylation of the NHIP gene compared to a control sample indicates an increased risk of the offspring for developing an ASD.
A method for detecting an NHIP peptide in a subject, the method comprising:
- obtaining a biological sample from the subject;
- and
- detecting the presence of the NHIP peptide by contacting the biological sample with an anti-NHIP antibody and detecting binding between the NHIP peptide and the antibody.
A method for preventing an autism spectrum disorder (ASD) in an offspring, the method comprising:
- administering a vitamin to the mother of the offspring before and/or during pregnancy, wherein the mother has decreased expression and/or DNA methylation of the NHIP gene in a biological sample compared to a control sample.
A method for preventing or reducing a risk of an offspring for developing an autism spectrum disorder (ASD), the method comprising:
- i) selecting a mother or potential mother of the offspring, wherein the mother or potential mother is selected based on having decreased expression and/or DNA methylation of the NHIP gene in a biological sample compared to a control sample;
- and
- ii) administering a vitamin to the mother or potential mother before and/or during pregnancy, thereby preventing or reducing the risk that the offspring develops an ASD.
A method for preventing or reducing a risk of an offspring for developing an autism spectrum disorder (ASD), the method comprising:
- administering a therapeutically effective amount of an NHIP gene, an NHIP RNA, or an NHIP peptide, to the mother of the offspring before and/or during pregnancy, thereby preventing or reducing the risk of the offspring for developing an ASD.
A plasmid or vector comprising the NHIP gene, or DNA encoding an NHIP RNA or peptide.
An isolated peptide comprising an amino acid sequence having at least about 80% sequence identity to SEQ ID NO:1.
A kit comprising reagents for detecting expression of an NHIP RNA or NHIP peptide.
An array comprising one or more nucleic acid sequences or probes that are capable of hybridizing to an NHIP RNA.
An array comprising one or more agents that bind to an NHIP peptide immobilized on a solid support.
A method for sequencing an NHIP gene sequence, comprising amplifying all or part of an NHIP gene from a biological sample obtained from a subject using a set of primers to produce amplified nucleic acid;
- and sequencing the amplified nucleic acid.
Dependencies are inferred from the claim text.